145 related articles for article (PubMed ID: 15790761)
1. Reduced intestinal fat absorptive capacity but enhanced susceptibility to diet-induced fatty liver in mice heterozygous for ApoB38.9 truncation.
Lin X; Yue P; Xie Y; Davidson NO; Sakata N; Ostlund RE; Chen Z; Schonfeld G
Am J Physiol Gastrointest Liver Physiol; 2005 Jul; 289(1):G146-52. PubMed ID: 15790761
[TBL] [Abstract][Full Text] [Related]
2. Fatty liver and insulin resistance: not always linked.
Schonfeld G; Yue P; Lin X; Chen Z
Trans Am Clin Climatol Assoc; 2008; 119():217-23; discussion 223-4. PubMed ID: 18596860
[TBL] [Abstract][Full Text] [Related]
3. A targeted apoB38.9 mutation in mice is associated with reduced hepatic cholesterol synthesis and enhanced lipid peroxidation.
Lin X; Chen Z; Yue P; Averna MR; Ostlund RE; Watson MA; Schonfeld G
Am J Physiol Gastrointest Liver Physiol; 2006 Jun; 290(6):G1170-6. PubMed ID: 16455790
[TBL] [Abstract][Full Text] [Related]
4. Absence of fatty liver in familial hypobetalipoproteinemia linked to chromosome 3p21.
Yue P; Tanoli T; Wilhelm O; Patterson B; Yablonskiy D; Schonfeld G
Metabolism; 2005 May; 54(5):682-8. PubMed ID: 15877300
[TBL] [Abstract][Full Text] [Related]
5. Normal intestinal dietary fat and cholesterol absorption, intestinal apolipoprotein B (ApoB) mRNA levels, and ApoB-48 synthesis in a hypobetalipoproteinemic kindred without any ApoB truncation.
Pulai JI; Averna M; Srivastava RA; Latour MA; Clouse RE; Ostlund RE; Schonfeld G
Metabolism; 1997 Sep; 46(9):1095-100. PubMed ID: 9284903
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein A-IV expression in mouse liver enhances triglyceride secretion and reduces hepatic lipid content by promoting very low density lipoprotein particle expansion.
VerHague MA; Cheng D; Weinberg RB; Shelness GS
Arterioscler Thromb Vasc Biol; 2013 Nov; 33(11):2501-8. PubMed ID: 24030551
[TBL] [Abstract][Full Text] [Related]
7. Fatty liver in familial hypobetalipoproteinemia: triglyceride assembly into VLDL particles is affected by the extent of hepatic steatosis.
Schonfeld G; Patterson BW; Yablonskiy DA; Tanoli TS; Averna M; Elias N; Yue P; Ackerman J
J Lipid Res; 2003 Mar; 44(3):470-8. PubMed ID: 12562873
[TBL] [Abstract][Full Text] [Related]
8. Omega-3 fatty acid containing diets decrease plasma triglyceride concentrations in mice by reducing endogenous triglyceride synthesis and enhancing the blood clearance of triglyceride-rich particles.
Qi K; Fan C; Jiang J; Zhu H; Jiao H; Meng Q; Deckelbaum RJ
Clin Nutr; 2008 Jun; 27(3):424-30. PubMed ID: 18362042
[TBL] [Abstract][Full Text] [Related]
9. In vivo regulation of low-density lipoprotein receptor and apolipoprotein B gene expressions by dietary fat and cholesterol in inbred strains of mice.
Srivastava RA; Jiao S; Tang JJ; Pfleger BA; Kitchens RT; Schonfeld G
Biochim Biophys Acta; 1991 Oct; 1086(1):29-43. PubMed ID: 1683257
[TBL] [Abstract][Full Text] [Related]
10. A targeted apolipoprotein B-38.9-producing mutation causes fatty livers in mice due to the reduced ability of apolipoprotein B-38.9 to transport triglycerides.
Chen Z; Fitzgerald RL; Averna MR; Schonfeld G
J Biol Chem; 2000 Oct; 275(42):32807-15. PubMed ID: 10893242
[TBL] [Abstract][Full Text] [Related]
11. Saturated fat stimulates obesity and hepatic steatosis and affects gut microbiota composition by an enhanced overflow of dietary fat to the distal intestine.
de Wit N; Derrien M; Bosch-Vermeulen H; Oosterink E; Keshtkar S; Duval C; de Vogel-van den Bosch J; Kleerebezem M; Müller M; van der Meer R
Am J Physiol Gastrointest Liver Physiol; 2012 Sep; 303(5):G589-99. PubMed ID: 22700822
[TBL] [Abstract][Full Text] [Related]
12. Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease.
Morgan K; Uyuni A; Nandgiri G; Mao L; Castaneda L; Kathirvel E; French SW; Morgan TR
Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):843-54. PubMed ID: 18794597
[TBL] [Abstract][Full Text] [Related]
13. Reduced susceptibility to cholesterol gallstone formation in mice that do not produce apolipoprotein B48 in the intestine.
Wang HH; Wang DQ
Hepatology; 2005 Oct; 42(4):894-904. PubMed ID: 16175613
[TBL] [Abstract][Full Text] [Related]
14. Ezetimibe improves high fat and cholesterol diet-induced non-alcoholic fatty liver disease in mice.
Zheng S; Hoos L; Cook J; Tetzloff G; Davis H; van Heek M; Hwa JJ
Eur J Pharmacol; 2008 Apr; 584(1):118-24. PubMed ID: 18329014
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein B gene mutations and fatty liver in Japanese hypobetalipoproteinemia.
Katsuda S; Kawashiri MA; Inazu A; Tada H; Tsuchida M; Kaneko Y; Nozue T; Nohara A; Okada T; Kobayashi J; Michishita I; Mabuchi H; Yamagishi M
Clin Chim Acta; 2009 Jan; 399(1-2):64-8. PubMed ID: 18848826
[TBL] [Abstract][Full Text] [Related]
16. Ezetimibe decreases SREBP-1c expression in liver and reverses hepatic insulin resistance in mice fed a high-fat diet.
Muraoka T; Aoki K; Iwasaki T; Shinoda K; Nakamura A; Aburatani H; Mori S; Tokuyama K; Kubota N; Kadowaki T; Terauchi Y
Metabolism; 2011 May; 60(5):617-28. PubMed ID: 20673929
[TBL] [Abstract][Full Text] [Related]
17. Adiponectin knockout mice on high fat diet develop fibrosing steatohepatitis.
Asano T; Watanabe K; Kubota N; Gunji T; Omata M; Kadowaki T; Ohnishi S
J Gastroenterol Hepatol; 2009 Oct; 24(10):1669-76. PubMed ID: 19788607
[TBL] [Abstract][Full Text] [Related]
18. Combined effects of rosiglitazone and conjugated linoleic acid on adiposity, insulin sensitivity, and hepatic steatosis in high-fat-fed mice.
Liu LF; Purushotham A; Wendel AA; Belury MA
Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1671-82. PubMed ID: 17322064
[TBL] [Abstract][Full Text] [Related]
19. Effects of dietary conjugated linoleic acid at high-fat levels on triacylglycerol regulation in mice.
Andreoli MF; Gonzalez MA; Martinelli MI; Mocchiutti NO; Bernal CA
Nutrition; 2009 Apr; 25(4):445-52. PubMed ID: 19091510
[TBL] [Abstract][Full Text] [Related]
20. Amino terminal 38.9% of apolipoprotein B-100 is sufficient to support cholesterol-rich lipoprotein production and atherosclerosis.
Chen Z; Fitzgerald RL; Saffitz JE; Semenkovich CF; Schonfeld G
Arterioscler Thromb Vasc Biol; 2003 Apr; 23(4):668-74. PubMed ID: 12615667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
